Loading: 100%
India Globalization Capital, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker IGCno data available
Financial year endsFY ends End of Marchno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,000,150,300,450,60
datesClosing price (adj.)
13.10.20170.38
11.10.20170.41
04.10.20170.41
27.09.20170.37
20.09.20170.40
13.09.20170.34
06.09.20170.31
30.08.20170.33
23.08.20170.34
16.08.20170.36
09.08.20170.39
02.08.20170.42
26.07.20170.41
19.07.20170.36
12.07.20170.38
05.07.20170.40
27.06.20170.47
20.06.20170.41
13.06.20170.44
06.06.20170.43
30.05.20170.42
23.05.20170.42
16.05.20170.37
09.05.20170.39
02.05.20170.47
25.04.20170.48
18.04.20170.47
11.04.20170.52
04.04.20170.57
28.03.20170.41
21.03.20170.42
14.03.20170.33
07.03.20170.32
28.02.20170.32
21.02.20170.33
14.02.20170.27
07.02.20170.27
31.01.20170.27
24.01.20170.26
17.01.20170.29
10.01.20170.30
03.01.20170.29
27.12.20160.30
19.12.20160.30
12.12.20160.36
05.12.20160.22
28.11.20160.27
21.11.20160.33
14.11.20160.34
07.11.20160.37
31.10.20160.42
24.10.20160.44
17.10.20160.40
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
0.38n/a
Market Capitalisation
in million USD
9n/a
Enterprise Value
in million USD
10n/a
Common Shares Outstanding
as per Jun 30, 2016
23,265,531n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
18,507,288n/a
Average Diluted Shares Outstanding
TTM
18,507,288n/a
Index Membership
n/a
Business Summary
India Globalization Capital Inc is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 5n/a
Gross Profit 1n/a
Operating Income -3n/a
EBITDA -2n/a
Net Profit -3n/a
Balance Sheet
Cash and Cash Equivalents 1n/a
Receivables 1n/a
Total Current Assets 4n/a
PP&E 7n/a
Total Assets 18n/a
Accounts Payable 0n/a
Current Debt 2n/a
Total Current Liabilities 3n/a
Long-Term Debt 1n/a
Total Liabilities 5n/a
Total Equity 14n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital 2n/a
Operating Cash Flow 1n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 1n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 15.1%n/a
Operating Margin -55.2%n/a
Net Profit Margin -59.2%n/a
Return on Equity -20.9%n/a
Return on Assets -15.4%n/a
Per Share Figures
Basic EPS -0.15n/a
Diluted EPS -0.15n/a
Sales per Share 0.26n/a
Book Value per Share 0.71n/a
FCF per Share -0.01n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -2.50n/a
Price to Sales Ratio 1.47n/a
Price to Book Value 0.52n/a
Price to Free Cash Flow -36.04n/a
Valuation Metrics
EV/EBITDA -5.26n/a
EV/Sales 2.17n/a
Book to Market Value 1.54n/a
Other Ratios
Current Ratio 103.2%n/a
Liabilities to Equity Ratio 36.1%n/a
Debt to Assets Ratio 13.0%n/a
Profit & Loss StatementP&L data quality: 81% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
4
4
8
2
8
6
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-4
-5
-6
-2
-7
-6
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
0
-1
2
0
1
1
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-8
-6
-4
-3
-5
-3
Selling, General & Administrative
-7
-5
-3
-2
-4
-3
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
Depreciation & Amortization
-1
-1
-1
-1
-1
-1
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-8
-6
-2
-3
-4
-3
Non-Operating Income (Loss)
-1
0
0
-1
0
0
Interest Expense, net
-1
-1
0
0
0
0
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-9
-7
-2
-3
-5
-3
Abnormal Gains (Losses)
-8
-1
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-17
-8
-3
-3
-5
-3
Income Tax (Expense) Benefit, net
-4
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-21
-8
-2
-3
-5
-3
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-21
-8
-2
-3
-5
-3
Minority Interest
1
0
0
0
0
0
Net Income
-20
-8
-2
-3
-5
-3
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-20
-8
-2
-3
-5
-3
Remarks
restated on Jul 16, 2012 n/a
calculated values,
restated on Jul 15, 2014 n/a
calculated values,
restated on Jul 15, 2014 n/a
calculated values,
restated on Jul 14, 2015 n/a
calculated values,
restated on Jul 14, 2016 n/a
calculated values,
restated on Jul 14, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
2
1
1
1
1
1
Cash & Cash Equivalents
2
1
1
1
1
1
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
3
2
1
1
1
1
Accounts Receivable, Net
3
2
1
1
1
1
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
0
0
1
1
0
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
2
3
2
2
2
1
Prepaid Expenses
1
3
2
2
2
1
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
7
5
4
4
4
4
Property, Plant & Equipment, Net
1
8
8
8
8
7
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
1
1
0
0
0
5
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
10
11
7
6
8
3
Intangible Assets
0
4
1
0
0
0
Goodwill
0
1
0
0
1
1
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
6
5
5
5
6
1
Miscellaneous Long Term Assets
3
1
1
0
0
1
Total Noncurrent Assets
12
20
15
14
16
15
Total Assets
18
25
19
18
20
19
Liabilities and owners' equity
Payables & Accruals
2 1661112
1 1253855
1 1067662
1 551845
1 596836
1 630742
Accounts Payable
1 1311963
0 337145
1 600702
0 133365
0 174584
0 330631
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 349149
1 916710
0 466960
0 418480
0 422252
0 300111
Short Term Debt
5 4821343
2 2010010
0 0
0 0
1 1280356
2 1827762
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 94892
1 1232155
1 757313
0 478832
1 570692
1 740557
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 135980
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 94892
1 1096175
1 757313
0 478832
1 570692
1 740557
Total Current Liabilities
7 6577347
4 4496020
2 1824975
1 1030677
2 2447884
3 3199061
Long Term Debt
0 0
0 0
2 1800000
2 1800000
2 2123904
1 801467
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
4 4291863
5 4947875
1 653388
1 758379
1 1009889
1 910583
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
1 713897
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
4 4291863
4 4233978
1 653388
1 758379
1 1009889
1 910583
Total Noncurrent Liabilities
4 4291863
5 4947875
2 2453388
3 2558379
3 3133793
2 1712050
Total Liabilities
11 10869210
9 9443895
4 4278363
4 3589056
6 5581677
5 4911111
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
39 38861809
55 54827959
56 56154073
58 58363771
63 63481395
66 65887570
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-30 -29692907
-37 -37444832
-40 -39697179
-43 -42719772
-47 -47333955
-50 -50142199
Other Equity
-3 -2502596
-3 -2542453
-2 -2020764
-2 -2016815
-2 -1913585
-2 -2269357
Equity Before Minority Interest
7 6666306
15 14840674
14 14436130
14 13627184
14 14233855
13 13476014
Minority Interest
1 626553
1 975509
1 538100
1 518112
1 515927
0 472057
Total Equity
7 7292859
16 15816183
15 14974230
14 14145296
15 14749782
14 13948071
Total Liabilities & Equity
18 18162069
25 25260078
19 19252593
18 17734352
20 20331459
19 18859182
Remarks restated on Jul 16, 2012 n/a restated on Jul 15, 2014 n/a restated on Jul 15, 2014 n/a restated on Jul 14, 2015 n/a restated on Jul 14, 2016 n/a restated on Aug 16, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-21
-8
-2
-3
-5
-3
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
1
1
1
1
1
1
Non-Cash Items
18
1
2
1
2
1
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
0
1
1
-1
0
1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
-3
-5
1
-2
-3
0
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
3
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
2
0
0
-1
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
0
5
0
0
-1
0
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
-1
0
0
0
-1
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
4
0
0
2
3
2
Increase in Capital Stock
4
0
0
2
3
2
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
3
-1
0
2
3
1
Net Cash Before Disc. Operations and FX
1
-1
1
0
0
1
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
1
-1
1
0
0
1
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
1
-1
1
0
0
1
Remarks
restated on Jul 16, 2012 n/a
calculated values,
restated on Jul 15, 2014 n/a
calculated values,
restated on Jul 15, 2014 n/a
calculated values,
restated on Jul 14, 2015 n/a
calculated values,
restated on Jul 14, 2016 n/a
calculated values,
restated on Jul 14, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo